Agennix hires Jill Porter as senior vice-president
This article was originally published in Scrip
Executive Summary
Biopharmaceutical company Agennix has appointed Dr Jill Porter senior vice-president of pharmaceutical development, reporting to Dr Rajesh Malik, the company's chief medical officer. Dr Porter has held senior executive positions with responsibility for manufacturing and process development at Taligen Therapeutics, Altus Pharmaceuticals and, most recently, Alexion Pharmaceuticals.